143 related articles for article (PubMed ID: 20175736)
1. Circulating and tissue-derived isoforms of bone alkaline phosphatase in Paget's disease of bone.
Magnusson P; Davie MW; Sharp CA
Scand J Clin Lab Invest; 2010 Apr; 70(2):128-35. PubMed ID: 20175736
[TBL] [Abstract][Full Text] [Related]
2. Isoforms of bone alkaline phosphatase: characterization and origin in human trabecular and cortical bone.
Magnusson P; Larsson L; Magnusson M; Davie MW; Sharp CA
J Bone Miner Res; 1999 Nov; 14(11):1926-33. PubMed ID: 10571693
[TBL] [Abstract][Full Text] [Related]
3. Assessment of the serum levels of bone alkaline phosphatase with a new immunoradiometric assay in patients with metabolic bone disease.
Garnero P; Delmas PD
J Clin Endocrinol Metab; 1993 Oct; 77(4):1046-53. PubMed ID: 8104954
[TBL] [Abstract][Full Text] [Related]
4. Effect of chronic renal failure on bone turnover and bone alkaline phosphatase isoforms.
Magnusson P; Sharp CA; Magnusson M; Risteli J; Davie MW; Larsson L
Kidney Int; 2001 Jul; 60(1):257-65. PubMed ID: 11422759
[TBL] [Abstract][Full Text] [Related]
5. Different responses of bone alkaline phosphatase isoforms during recombinant insulin-like growth factor-I (IGF-I) and during growth hormone therapy in adults with growth hormone deficiency.
Magnusson P; Degerblad M; Sääf M; Larsson L; Thorén M
J Bone Miner Res; 1997 Feb; 12(2):210-20. PubMed ID: 9041052
[TBL] [Abstract][Full Text] [Related]
6. Serum osteocalcin and bone and liver alkaline phosphatase isoforms in healthy children and adolescents.
Magnusson P; Häger A; Larsson L
Pediatr Res; 1995 Dec; 38(6):955-61. PubMed ID: 8618800
[TBL] [Abstract][Full Text] [Related]
7. Discriminative value of biochemical markers of bone turnover in assessing the activity of Paget's disease.
Alvarez L; Guañabens N; Peris P; Monegal A; Bedini JL; Deulofeu R; Martinez de Osaba MJ; Muñoz-Gomez J; Rivera-Fillat F; Ballesta AM
J Bone Miner Res; 1995 Mar; 10(3):458-65. PubMed ID: 7785468
[TBL] [Abstract][Full Text] [Related]
8. Clinical significance of bone alkaline phosphatase isoforms, including the novel B1x isoform, in mild to moderate chronic kidney disease.
Haarhaus M; Fernström A; Magnusson M; Magnusson P
Nephrol Dial Transplant; 2009 Nov; 24(11):3382-9. PubMed ID: 19542194
[TBL] [Abstract][Full Text] [Related]
9. Increased circulating Dickkopf-1 in Paget's disease of bone.
Marshall MJ; Evans SF; Sharp CA; Powell DE; McCarthy HS; Davie MW
Clin Biochem; 2009 Jul; 42(10-11):965-9. PubMed ID: 19389391
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of circulating type I procollagen propeptides in patients with Paget's disease of bone.
Bonnin MR; Moragues C; Nolla JM; Lirón FJ; Roig-Escofet D; Navarro MA
Clin Chem Lab Med; 1998 Jan; 36(1):53-5. PubMed ID: 9594087
[TBL] [Abstract][Full Text] [Related]
11. Paget's disease of bone in The Netherlands: a population-based radiological and biochemical survey--the Rotterdam Study.
Eekhoff ME; van der Klift M; Kroon HM; Cooper C; Hofman A; Pols HA; Papapoulos SE
J Bone Miner Res; 2004 Apr; 19(4):566-70. PubMed ID: 15005843
[TBL] [Abstract][Full Text] [Related]
12. Differences in sialic acid residues among bone alkaline phosphatase isoforms: a physical, biochemical, and immunological characterization.
Magnusson P; Farley JR
Calcif Tissue Int; 2002 Dec; 71(6):508-18. PubMed ID: 12232676
[TBL] [Abstract][Full Text] [Related]
13. [Clinical evaluation of the results of the Sr85 test and of bone alkaline phosphatase isoenzyme activity].
Stĕpán J; Kolár J; Stĕpán J; Susta A
Z Rheumatol; 1977; 36(3-4):120-5. PubMed ID: 871069
[TBL] [Abstract][Full Text] [Related]
14. Long-term biochemical response after bisphosphonate therapy in Paget's disease of bone. Proposed intervals for monitoring treatment.
Alvarez L; Peris P; Guañabens N; Vidal S; Quintó L; Monegal A; Pons F; Ballesta AM; Muñoz-Gómez J
Rheumatology (Oxford); 2004 Jul; 43(7):869-74. PubMed ID: 15054158
[TBL] [Abstract][Full Text] [Related]
15. Biochemical assessment of Paget's disease of bone.
Shankar S; Hosking DJ
J Bone Miner Res; 2006 Dec; 21 Suppl 2():P22-7. PubMed ID: 17229003
[TBL] [Abstract][Full Text] [Related]
16. Bone alkaline phosphatase in Paget's disease.
Deftos LJ; Wolfert RL; Hill CS
Horm Metab Res; 1991 Nov; 23(11):559-61. PubMed ID: 1816067
[TBL] [Abstract][Full Text] [Related]
17. Sarcoma arising in Paget's disease of bone: declining incidence and increasing age at presentation.
Mangham DC; Davie MW; Grimer RJ
Bone; 2009 Mar; 44(3):431-6. PubMed ID: 19064007
[TBL] [Abstract][Full Text] [Related]
18. Analytical and clinical performance characteristics of Tandem-MP Ostase, a new immunoassay for serum bone alkaline phosphatase.
Broyles DL; Nielsen RG; Bussett EM; Lu WD; Mizrahi IA; Nunnelly PA; Ngo TA; Noell J; Christenson RH; Kress BC
Clin Chem; 1998 Oct; 44(10):2139-47. PubMed ID: 9761247
[TBL] [Abstract][Full Text] [Related]
19. Serum OPG and RANKL levels before and after intravenous bisphosphonate treatment in Paget's disease of bone.
Martini G; Gennari L; Merlotti D; Salvadori S; Franci MB; Campagna S; Avanzati A; De Paola V; Valleggi F; Nuti R
Bone; 2007 Feb; 40(2):457-63. PubMed ID: 16979395
[TBL] [Abstract][Full Text] [Related]
20. Paget's disease of bone in New Zealand: continued decline in disease severity.
Cundy HR; Gamble G; Wattie D; Rutland M; Cundy T
Calcif Tissue Int; 2004 Nov; 75(5):358-64. PubMed ID: 15455187
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
